Welcome to LookChem.com Sign In|Join Free
  • or
C20H17N3O2S2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1135236-62-2

Post Buying Request

1135236-62-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1135236-62-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1135236-62-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,5,2,3 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1135236-62:
(9*1)+(8*1)+(7*3)+(6*5)+(5*2)+(4*3)+(3*6)+(2*6)+(1*2)=122
122 % 10 = 2
So 1135236-62-2 is a valid CAS Registry Number.

1135236-62-2Relevant academic research and scientific papers

Synthesis of some sulfonamides, disubstituted sulfonylureas or thioureas and some structurally related variants. A class of promising antitumor agents

Faidallah, Hassan M.,Al-Saadi, Mohammed S.,Rostom, Sherif A. F.,Fahmy, Hesham T. Y.

, p. 300 - 318 (2008/12/21)

Some new benzenesulfonamides, disubstituted sulfonylureas, and sulfonylthioureas substituted basically with 3-(2-thienyl or 3-pyridyl)-indeno[1,2-c]pyrazol(in)e counterpart were synthesized to be evaluated for their in vitro antitumor activity. Some of the thioureido derivatives were cyclized to the corresponding five-membered thiazolidinons, thiazolines, and the six-membered thiazinones as interesting structure variants. According to the protocol of the National Cancer Institute (NCI) in vitro disease-oriented human cells screening panel assay, 13 compounds showed promising broad spectrum antitumor activity. In general, compounds containing the thienyl moiety displayed better antitumor spectra than those containing the pyridyl moiety. Compound 5, 4-(3-(2-thienyl)-3H-indeno[1,2-c]pyrazol-2-yl)- benzenesulfonamide [GI50, TGI, and LC50 (MG-MID) values of 13.2, 33.1 and 69.2 μM, respectively] proved to be the most active member in this study with variable degrees of potencies against all the tested subpanel tumor cell lines and particular effectiveness against the leukemia and prostate subpanels at both the GI50 (3.30 and 8.68 μM, respectively) and the TGI levels (15.7 and 22.3 μM, respectively).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1135236-62-2